Daniel E. Everitt

5.9k citations
52 papers · 3.8k indexed · 1 hit paper · h-index 28

Daniel E. Everitt

52 papers receiving 3.7k citations

Hit Papers

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis5852020202620222024100200300400500

Peers

Daniel E. Everitt
Comparison fields: 5 of 144
  • Infectious Diseases 1.4k
  • Geriatrics and Gerontology 263
  • Family Practice 75
  • Epidemiology 1.1k
  • Ophthalmology 267
Replace Swu‐Jane Lin with:
Swu‐Jane Lin United States
Susan E. Tett Australia
Chantal Csajka Switzerland
Kenneth Nugent United States
Kevin P. High United States
Edeltraut Garbe Germany
Shlomo Vinker Israel
Esther W. Chan Hong Kong
Mary H. H. Ensom Canada
Fang Liu China
Daniel E. Everitt relative to Swu‐Jane Lin United States Swu‐Jane Lin's profile →
Citations per field
00.5×
Swu‐Jane Lin · 1×
Citations per year

Countries citing papers authored by Daniel E. Everitt

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Everitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Everitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Everitt more than expected).

Fields of papers citing papers by Daniel E. Everitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Everitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Everitt. The network helps show where Daniel E. Everitt may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel E. Everitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel E. Everitt Line = papers co-authored together Daniel E. Everitt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202118
2 202121
3 202048
4 20209
5 201992
6 2015165
7 2015184
8 2007149
9 2006168
10
A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis.
200617
11 2004212
12 199812
13 199857
14 199630
15 19962
16 199641
17 1993233
18 1991129
19 199072
20 19871

About Daniel E. Everitt

Daniel E. Everitt is a scholar working on Infectious Diseases, Neuropsychology and Physiological Psychology, Ophthalmology, Pharmacology and Applied Microbiology and Biotechnology, having authored 52 papers that have together received 3.8k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (15 papers), Pneumonia and Respiratory Infections (8 papers), Glaucoma and retinal disorders (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Mycobacterium research and diagnosis (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Geriatric Care and Nursing Homes (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Infectious Diseases (1.4k citations), Geriatrics and Gerontology (263 citations), Family Practice (75 citations), Epidemiology (1.1k citations) and Ophthalmology (267 citations). Daniel E. Everitt has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Jerry Avorn, Carl M. Mendel, Stephen B. Soumerai, Christo van Niekerk, Melvin Spigelman, Andreas H. Diacon, Rodney Dawson, Mary Ann Mascelli, Roselie A. Bright and Amour Venter. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of the American Geriatrics Society, Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology and Journal of Glaucoma.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026